Conversely, many other studies have not described a positive association with APS manifestations [33–35] and adding aPL IgA to the current criterion panel does not increase odds ratios for thrombosis nor pregnancy morbidity [36]. Here, CD79A is linked to autoimmune polyendocrinopathy.